Hyperglycemia Management
Hyperglycemia Management - Related Videos
13:35
Acute and Chronic Models of Hyperglycemia in Zebrafish: A Method to Assess the Impact of Hyperglycemia on Neurogenesis and the Biodistribution of Radiolabeled Molecules
0 Views •
Cited by 25 •
2017
This work describes methods to establish acute and chronic hyperglycemia models in zebrafish. The aim is to investigate the impact of hyperglycemia on physiological processes, such as constitutive and injury-induced neurogenesis. The work also highlights the use of zebrafish to follow radiolabeled molecules (here, [18F]-FDG) using PET/CT.
01:29
Hyperglycemia
0 Views •
2026
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:34
Early Intervention and Pain Management
0 Views •
2026
All animal procedures described here must be conducted in accordance with institutional animal ethics guidelines and approved by IACUC. All procedures must follow the principles of the 3Rs—Replacement, Reduction, and Refinement—and must be performed by trained personnel. Monitoring Animals for Signs of Pain and Distress Recognizing early signs of pain is essential for ethical animal research. Animals are routinely monitored using behavioral, physical, and physiological parameters that reflect...
05:49
Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish
0 Views •
Cited by 6 •
2021
This protocol noninvasively induces hyperglycemia in zebrafish for up to 8 weeks. Using this protocol, an in-depth study of the adverse effects of hyperglycemia can be made.
01:33
Breeding Management in Rodent Studies
0 Views •
2026
All animal procedures described here must be conducted in accordance with institutional animal ethics guidelines and approved by IACUC. All procedures must follow the principles of the 3Rs—Replacement, Reduction, and Refinement—and must be performed by trained personnel. Breeding management supports the 3Rs by minimizing unnecessary animal production and ensuring that only the number of animals required for a study is generated. Effective breeding strategies help reduce surplus animals and...
FAQs
Monitoring is central because isolated glucose values may not show whether elevations are persistent, intermittent, or associated with a particular intervention. Blood glucose testing or continuous glucose monitoring reveals patterns that can guide changes in nutrition, physical activity, insulin, or other glucose-lowering medicines. This pattern-based approach supports more targeted control.
The appropriate plan depends on why glucose is elevated and how severe the elevation is. Clinicians consider the diabetes type, coexisting medical conditions, and individual treatment goals before selecting or adjusting therapy. Consequently, the same glucose value may lead to different management decisions in different patients, rather than a uniform regimen.
Effective treatment requires balancing glucose lowering with protection from hypoglycemia. Monitoring results can show whether insulin or another medicine is producing the intended improvement or lowering glucose too far, allowing therapy, nutrition, or activity recommendations to be adjusted. Better glycemic control should therefore not be pursued without attention to treatment-related low glucose.
Hyperglycemia management follows a repeating workflow: measure glucose, identify meaningful patterns, evaluate the patient’s cause and severity, and adjust nutrition, physical activity, insulin, or other glucose-lowering medicines. Subsequent monitoring shows whether the change improves control. This sequence turns measurements into individualized decisions instead of treating a single reading in isolation.
Blood glucose monitoring and continuous glucose monitoring provide the main information used to guide decisions. Blood testing supplies glucose measurements, while continuous monitoring follows glucose over time, making each useful for recognizing patterns. These data help determine whether lifestyle measures or prescribed therapies require adjustment and whether control is moving toward the patient’s goals.
When glucose is severely elevated, prompt recognition and treatment become especially important because hyperglycemia can progress to diabetic ketoacidosis or hyperosmolar hyperglycemic state. In this context, management is not limited to long-term risk reduction; it also addresses an immediate threat. The severity of elevation therefore influences urgency as well as therapy selection.
Sustained glycemic control has relevance beyond the glucose measurement itself. Over time, it supports protection of cardiovascular, renal, neurologic, and ocular systems, which is why management plans evaluate more than short-term readings. This broader medical context helps explain why monitoring and treatment adjustments remain important even when a patient is not experiencing an acute emergency.